Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Winyard of the NHS Executive wrote to NHS Trust medical directors informing them that they had been told by ethics experts and advisory bodies that there was no need to inform patients of their exposure.

  • Read more about Dr Winyard of the NHS Executive wrote to NHS Trust medical directors informing them that they had been told by ethics experts and advisory bodies that there was no need to inform patients of their exposure.

As part of risk management the Creutzfeldt-Jakob Disease Incidents Panel sought to balance the individual's "right to know" and "right not to know" about possible exposure to risk.

  • Read more about As part of risk management the Creutzfeldt-Jakob Disease Incidents Panel sought to balance the individual's "right to know" and "right not to know" about possible exposure to risk.

An NHS Blood and Transplant meeting discussed and agreed on various measures on the management of patients who received blood from donors who later developed vCJD.

  • Read more about An NHS Blood and Transplant meeting discussed and agreed on various measures on the management of patients who received blood from donors who later developed vCJD.

"The Lancet" published an article which included reference to a case where a patient who had received a donation of blood in 1996 from an infected donor subsequently died of vCJD.

  • Read more about "The Lancet" published an article which included reference to a case where a patient who had received a donation of blood in 1996 from an infected donor subsequently died of vCJD.

A letter sent by the Scottish Office to NHS Trust medical directors stated that they had been told by ethics experts and advisory bodies that there was no need to inform patients who had received nvCJD-implicated blood components or products.

  • Read more about A letter sent by the Scottish Office to NHS Trust medical directors stated that they had been told by ethics experts and advisory bodies that there was no need to inform patients who had received nvCJD-implicated blood components or products.

Professor Doyal wrote to Dr Hewitt of the National Blood Authority expressing his view that donors who were told their blood would not be used must be informed why that was, and that it would be illegal and immoral to allow someone to give blood when it was known that the donation would be destroyed.

  • Read more about Professor Doyal wrote to Dr Hewitt of the National Blood Authority expressing his view that donors who were told their blood would not be used must be informed why that was, and that it would be illegal and immoral to allow someone to give blood when it was known that the donation would be destroyed.

The Lothian Research Ethics Committee refused the National Creutzfeldt-Jakob Disease Research and Surveillance Unit's application for renewed ethical approval of the Transfusion Medicine Epidemiology Review study.

  • Read more about The Lothian Research Ethics Committee refused the National Creutzfeldt-Jakob Disease Research and Surveillance Unit's application for renewed ethical approval of the Transfusion Medicine Epidemiology Review study.

The Standing Advisory Committee on Transfusion Transmitted Infections proposed a study to check on recipients of those blood donors who later developed vCJD.

  • Read more about The Standing Advisory Committee on Transfusion Transmitted Infections proposed a study to check on recipients of those blood donors who later developed vCJD.

Blood transfusion services throughout the UK were required to ask all blood donors whether they had a family history of CJD and where a close family member with CJD was a direct bloodline relative the potential donor was to be advised not to give blood.

  • Read more about Blood transfusion services throughout the UK were required to ask all blood donors whether they had a family history of CJD and where a close family member with CJD was a direct bloodline relative the potential donor was to be advised not to give blood.

From 1 April 1998 donors who had had brain surgery before August 1992 were permanently deferred.

  • Read more about From 1 April 1998 donors who had had brain surgery before August 1992 were permanently deferred.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 585
  • Page 586
  • Page 587
  • Page 588
  • Current page 589
  • Page 590
  • Page 591
  • Page 592
  • Page 593
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.